Pharmacy Chain 36.6

Pharmacy Chain 36.6 is a Russian company from the retail sector of medicine and beauty products. The company was founded in 1991 and its headquarters are located in Moscow. The Chain was the first Russian pharmaceutical company to conduct an IPO. At the end of 2013 the company merged with the A.V.E. chain.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Pharmacy Chain 36.6 balance sheet

Report period2021 2022 2023 2024 2025 Q2 26
End date of the reporting period
Capitalization, ₽
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Pharmacy Chain 36.6 cash flows

Report period2021 2022 2023 2024 2025 Q2 26 TTM
End date of the reporting period
Sales
Gross profit
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Pharmacy Chain 36.6 multipliers

Report period2021 2022 2023 2024 2025 Q2 26 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Pharmacy Chain 36.6 profitability

Report period2021 2022 2023 2024 2025 Q2 26 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Pharmacy Chain 36.6 assets
Pharmacy Chain 36.6 cash flows
Pharmacy Chain 36.6 dividends
0%

Pharmacy Chain 36.6 shares

TickerNameTypeNominal valueISINPrice
APTK:RMPharmacy Chain 36.6Common shareRUB 0.64RU0008081765RUB 6.004

Pharmacy Chain 36.6 bonds

NameIssue sizePriceYield
Pharmacy Chain 36.6 001P-01 (RUB)20,000,000 pcs.100%13.91%
Pharmacy Chain 36.6 002P-01 (RUB)10,000,000 pcs.99.95%14.38%
Pharmacy Chain 36.6 002P-02 (RUB)1,250,000 pcs.100%20.81%
Share capital structure of Pharmacy Chain 36.6
Pharmacy Chain 36.6 news
31.08.2026
Net profit of Pharmacy Chain 36.6 under IFRS for 6 months of 2026 amounted to ₽267 million, an increase of 7 times compared to ₽40 million in the previous year. Revenue grew by 9.7% to ₽56.07 billion, compared to ₽51.1 billion a year earlier.
17.08.2026
Total revenue with VAT for Pharmacy Network 36.6 for 6 months of 2026 amounted to ₽62.4 billion, an increase of 9.9% compared to the same period last year. Сompany also recorded positive EBITDA dynamics. Absolute value of the indicator amounted to ₽3.9 billion, with a profitability level of 9.9%.
06.08.2026
Company Pharmacy chain 36.6 acquired 83 retail outlets of the Moscow‑based pharmaceutical retailer Dialogue. Chain ranks 41st in the DSM Group’s rating, with a market share of 0.16%. Its turnover in the first quarter of 2026 amounted to ₽1 billion, an increase of 15% year‑on‑year. Transaction amount and other details have not been disclosed. According to a s...
10.07.2026
36.6 pharmacy chain has acquired the Trika pharmacy chain. The deal includes 45 pharmacies. Experts estimate the deal value at ₽540–700 million. Purchase of the chain will allow the company to strengthen its presence in Moscow, the Moscow region, and the Yaroslavl region, as well as expand into a new region, the Oryol region.
General information
Company namePharmacy Chain 36.6
Tags#pharmacy, #apothecary
SectorConsumer Staples / Food & Staples Retailing / Food & Staples Retailing / Drug Retail
Business addressg. Moskva Rossiyskaya Federaciya
Mailing address121096, gorod Moskva, ul. Vasilisy Kozhinoy, d.1, stroenie 1; 111024, gorod Moskva, ul. Aviamotornaya, dom 50, stroenie 2, pomeschenie 11, komn.10
CEONesterenko Vladimir Mihaylovich
Phone(495) 792-52-09
Websitepharmacychain366.ru
Information disclosuree-disclosure.ru